Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


03.01.2022

7 Gynecol Oncol
3 Hum Pathol
2 J Natl Cancer Inst
1 PLoS One
1 Tumour Biol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Gynecol Oncol

  1. BEESLEY VL, Ross TL, King MT, Campbell R, et al
    Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).
    Gynecol Oncol. 2021 Dec 23. pii: S0090-8258(21)01632.
    PubMed         Abstract available

  2. PHILP L, Alimena S, Ferris W, Saini A, et al
    Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer.
    Gynecol Oncol. 2021 Dec 22. pii: S0090-8258(21)01674.
    PubMed         Abstract available

  3. HARTER P, Mouret-Reynier MA, Pignata S, Cropet C, et al
    Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
    Gynecol Oncol. 2021 Dec 21. pii: S0090-8258(21)01673.
    PubMed         Abstract available

  4. TRAN DT, Vo VK, Le MT, Chuang L, et al
    Copenhagen Index versus ROMA in preoperative ovarian malignancy risk stratification: Result from the first Vietnamese prospective cohort study.
    Gynecol Oncol. 2021 May 13. pii: S0090-8258(21)00360.
    PubMed         Abstract available

  5. CABRERA S, Barahona-Orpinell M, Almansa-Gonzalez C, Padilla-Iserte P, et al
    Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer: Results of the COMBITEC study.
    Gynecol Oncol. 2021 May 12. pii: S0090-8258(21)00361.
    PubMed         Abstract available

  6. HICKEY M, Moss KM, Mishra GD, Krejany EO, et al
    What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
    Gynecol Oncol. 2021 May 7. pii: S0090-8258(21)00358.
    PubMed         Abstract available

  7. CAO L, Wei M, Liu Y, Fu J, et al
    Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Gynecol Oncol. 2021 May 6. pii: S0090-8258(21)00351.
    PubMed         Abstract available


    Hum Pathol

  8. SIATECKA H, Masand RP
    Brenner tumor associated with rete ovarii: a histologic and immunohistochemical analysis of six cases exploring the relationship between these entities.
    Hum Pathol. 2021;113:84-91.
    PubMed         Abstract available

  9. NIU N, Shen W, Zhong Y, Bast RC Jr, et al
    Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00054.
    PubMed         Abstract available

  10. ZHANG Y, Jeyachandran D, Desouki MM
    Grossly Unremarkable Cervix in Endometrial Carcinomas: LVSI and MELF Pattern may be Associated with High Incidence of Cervical Stromal Involvement.
    Hum Pathol. 2021 Apr 29. pii: S0046-8177(21)00069.
    PubMed         Abstract available


    J Natl Cancer Inst

  11. TAKAHASHI K
    Untangling the Relationship between Clonal Hematopoiesis and Ovarian Cancer Therapies.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486529. doi: 10.1093.
    PubMed        

  12. WEBER-LASSALLE K, Ernst C, Reuss A, Mollenhoff K, et al
    Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients with Ovarian Cancer.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486427. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  13. SAEED-VAFA D, Marchion DC, McCarthy SM, Hakam A, et al
    Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
    PLoS One. 2021;16:e0256615.
    PubMed         Abstract available


    Tumour Biol

  14. BLACKMAN A, Mitchell J, Rowswell-Turner R, Singh R, et al
    Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors.
    Tumour Biol. 2021;43:355-365.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: